Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions (Q38202698)

30 August 2017

title

Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions (English)

1 reference

30 August 2017

Parvin Zakeri-Milani

1

1 reference

30 August 2017

Hadi Valizadeh

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

7 April 2014

1 reference

Expert Opinion on Drug Metabolism & Toxicology

30 August 2017

published in

1 reference

30 August 2017

volume

10

1 reference

30 August 2017

issue

6

1 reference

30 August 2017

page(s)

859-871

1 reference

Effects of monoglycerides on P-glycoprotein: modulation of the activity and expression in Caco-2 cell monolayers

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

21 January 2018

Membrane transporters

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Transporter-mediated drug delivery: recent progress and experimental approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Polyspecific organic cation transporters: their functions and interactions with drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The superfamily of organic anion transporting polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Effects of orange juice on the pharmacokinetics of atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Grapefruit juice ingestion significantly reduces talinolol bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Interaction of organic cations with a newly identified plasma membrane monoamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Cell entry and export of nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Identification and characterization of a novel monoamine transporter in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The SLC22 family with transporters of organic cations, anions and zwitterions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The SLC16 gene family?from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The monocarboxylate transporter family--Structure and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Monocarboxylate transporter-mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The SLC16 gene family - structure, role and regulation in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

H(+)-linked transport of salicylic acid, an NSAID, in the human trophoblast cell line BeWo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Expression and membrane localization of MCT isoforms along the length of the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Identification of a unique monocarboxylate transporter (MCT3) in retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

TCDB: the Transporter Classification Database for membrane transport protein analyses and information

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Towards understanding promiscuity in multidrug efflux pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Human ATP-binding cassette (ABC) transporter family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Role of ABC transporters in lipid transport and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The role of ABC transporters in drug resistance, metabolism and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

ABC multidrug transporters: structure, function and role in chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Improving the stability and function of purified ABCB1 and ABCA4: the influence of membrane lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Human P-glycoprotein is active when the two halves are clamped together in the closed conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Regional absorption of fexofenadine in rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

P-glycoprotein Inhibition for Optimal Drug Delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

P-glycoprotein retains function when reconstituted into a sphingolipid- and cholesterol-rich environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Three decades of P-gp inhibitors: skimming through several generations and scaffolds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Acetaminophen inhibits intestinal p-glycoprotein transport activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Rhamnolipids enhance epithelial permeability in Caco-2 monolayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

P-glycoprotein mediated efflux in Caco-2 cell monolayers: the influence of herbals on digoxin transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The effect of grapefruit juice on drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Effects of itraconazole or grapefruit juice on the pharmacokinetics of telithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

A bitter melon extract inhibits the P-glycoprotein activity in intestinal Caco-2 cells: monoglyceride as an active compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Pharmacokinetic interactions of drugs with St John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Role of P-glycoprotein in pharmacokinetics: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

The applications of Vitamin E TPGS in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Advances in the use of tocols as drug delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.905543

10.1517/17425255.2014.905543

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference